GR900100688A - Novel macrocyclic compositions and new application method thereof - Google Patents

Novel macrocyclic compositions and new application method thereof

Info

Publication number
GR900100688A
GR900100688A GR90100688A GR900100688A GR900100688A GR 900100688 A GR900100688 A GR 900100688A GR 90100688 A GR90100688 A GR 90100688A GR 900100688 A GR900100688 A GR 900100688A GR 900100688 A GR900100688 A GR 900100688A
Authority
GR
Greece
Prior art keywords
application method
new application
novel macrocyclic
compositions
macrocyclic compositions
Prior art date
Application number
GR90100688A
Other languages
Greek (el)
Other versions
GR1001225B (en
Inventor
David Keith Donald
Mark Furber
David Norman Hardern
Paul Leff
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898920849A external-priority patent/GB8920849D0/en
Priority claimed from GB898920985A external-priority patent/GB8920985D0/en
Priority claimed from GB909006449A external-priority patent/GB9006449D0/en
Priority claimed from GB909012795A external-priority patent/GB9012795D0/en
Priority claimed from GB909014959A external-priority patent/GB9014959D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of GR900100688A publication Critical patent/GR900100688A/en
Publication of GR1001225B publication Critical patent/GR1001225B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GR900100688A 1989-09-14 1990-09-12 Novel macrocyclic compositions and new application method thereof GR1001225B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB898920849A GB8920849D0 (en) 1989-09-14 1989-09-14 Compound
GB898920985A GB8920985D0 (en) 1989-09-15 1989-09-15 Method of treatment
GB909006449A GB9006449D0 (en) 1990-03-22 1990-03-22 Compounds
GB909012795A GB9012795D0 (en) 1990-06-08 1990-06-08 Compounds
GB909014959A GB9014959D0 (en) 1990-07-06 1990-07-06 Method of treatment

Publications (2)

Publication Number Publication Date
GR900100688A true GR900100688A (en) 1992-01-20
GR1001225B GR1001225B (en) 1993-06-30

Family

ID=27516937

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100688A GR1001225B (en) 1989-09-14 1990-09-12 Novel macrocyclic compositions and new application method thereof

Country Status (7)

Country Link
EP (1) EP0491797A1 (en)
JP (1) JPH05500215A (en)
KR (1) KR920702219A (en)
GR (1) GR1001225B (en)
IE (1) IE903334A1 (en)
PT (1) PT95305A (en)
WO (1) WO1991004025A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208228A (en) * 1989-11-13 1993-05-04 Merck & Co., Inc. Aminomacrolides and derivatives having immunosuppressive activity
US5190950A (en) * 1990-06-25 1993-03-02 Merck & Co., Inc. Antagonists of immunosuppressive macrolides
US5342935A (en) * 1990-06-25 1994-08-30 Merck & Co., Inc. Antagonists of immunosuppressive macrolides
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
US5250678A (en) * 1991-05-13 1993-10-05 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5262533A (en) * 1991-05-13 1993-11-16 Merck & Co., Inc. Amino O-aryl macrolides having immunosuppressive activity
US5162334A (en) * 1991-05-13 1992-11-10 Merck & Co., Inc. Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
US5565560A (en) * 1991-05-13 1996-10-15 Merck & Co., Inc. O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5189042A (en) * 1991-08-22 1993-02-23 Merck & Co. Inc. Fluoromacrolides having immunosuppressive activity
CA2103453A1 (en) * 1991-09-05 1993-03-06 Jay R. Luly Macrocyclic immunomodulators
US5708002A (en) * 1991-09-05 1998-01-13 Abbott Laboratories Macrocyclic immunomodulators
ZA926812B (en) 1991-09-09 1993-04-28 Merck & Co Inc O-heteroaryl,o-alkylheteroaryl,o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosupressive activity
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
US5284877A (en) * 1992-06-12 1994-02-08 Merck & Co., Inc. Alkyl and alkenyl macrolides having immunosuppressive activity
US5284840A (en) * 1992-06-12 1994-02-08 Merck & Co., Inc. Alkylidene macrolides having immunosuppressive activity
GB9218597D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
GB9218027D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
US5693648A (en) * 1994-09-30 1997-12-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
GB9917158D0 (en) * 1999-07-21 1999-09-22 Fujisawa Pharmaceutical Co New use
AR035411A1 (en) * 2000-12-29 2004-05-26 Fujisawa Pharmaceutical Co USE OF A TACROLIMUS DERIVATIVE TO MANUFACTURE A NEUROTROPHIC AGENT, COMPOSITIONS AND MANUFACTURING ITEMS OR KITS THAT UNDERSTAND IT, METHOD FOR MANUFACTURING AN AGENT THAT UNDERSTANDS AND FABRICS AND GRAINTS WITH A NERVOUS CELL TREATED WITH THIS COMPOSITE
AU2003901023A0 (en) * 2003-03-04 2003-03-20 Fujisawa Pharmaceutical Co., Ltd. New use
CA2554045A1 (en) * 2004-01-20 2005-07-28 Astellas Pharma Inc. Method for treating erectile dysfunction
EP1963280B1 (en) * 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
JP2009203162A (en) * 2006-06-05 2009-09-10 Astellas Pharma Inc New method for producing macrolide compound
EA201991141A1 (en) 2016-11-10 2019-10-31 AMPLIFIERS BMP
JP2023529081A (en) * 2020-06-09 2023-07-07 ユニクエスト ピーティーワイ リミテッド Compounds for the prevention or treatment of skin cancer or skin precancer

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184162A2 (en) * 1984-12-03 1986-06-11 Fujisawa Pharmaceutical Co., Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
WO1989005304A1 (en) * 1987-12-09 1989-06-15 Fisons Plc Macrocyclic compounds
EP0349061A2 (en) * 1988-06-29 1990-01-03 Merck & Co. Inc. Immunosuppressant agent
EP0349049A2 (en) * 1988-06-29 1990-01-03 Merck & Co. Inc. Immunosuppressant compound
EP0356399A2 (en) * 1988-08-26 1990-02-28 Sandoz Ag Substituted 4-azatricyclo (22.3.1.04.9) octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184162A2 (en) * 1984-12-03 1986-06-11 Fujisawa Pharmaceutical Co., Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
WO1989005304A1 (en) * 1987-12-09 1989-06-15 Fisons Plc Macrocyclic compounds
EP0349061A2 (en) * 1988-06-29 1990-01-03 Merck & Co. Inc. Immunosuppressant agent
EP0349049A2 (en) * 1988-06-29 1990-01-03 Merck & Co. Inc. Immunosuppressant compound
EP0356399A2 (en) * 1988-08-26 1990-02-28 Sandoz Ag Substituted 4-azatricyclo (22.3.1.04.9) octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO1991004025A1 (en) 1991-04-04
KR920702219A (en) 1992-09-03
GR1001225B (en) 1993-06-30
EP0491797A1 (en) 1992-07-01
IE903334A1 (en) 1991-04-10
PT95305A (en) 1991-06-25
JPH05500215A (en) 1993-01-21

Similar Documents

Publication Publication Date Title
GR900100688A (en) Novel macrocyclic compositions and new application method thereof
GB9006142D0 (en) Composition and use
AU6487390A (en) Deodorizing and cleaning compositions and method
GB8917470D0 (en) Composition and method
AU619968B2 (en) Novel method and compounds
EP0502080A4 (en) Anti-inflammatory compositions and methods
ZA904844B (en) Masking composition and method
NZ234174A (en) Dihydroindenoindole derivatives and compositions containing them
GB8926051D0 (en) Lubricant method and compositions
GR900100627A (en) New cyclic derivatives and compositions containing them preparation method therefor
EP0386359A3 (en) Konjak-containing composition
GB2231575B (en) Command-curable composition
GB9016171D0 (en) Fungicidal compositions and method
GB8916151D0 (en) Composition
EP0433843A3 (en) Hollow shaft and method for its manufacture
GB9026896D0 (en) Method and composition
GB8922867D0 (en) Pharmaceutical method and compositions
GB8922866D0 (en) Pharmaceutical method and compositions
EP0434164A3 (en) Frying-fat composition
GB9010014D0 (en) Method and composition
GB9020384D0 (en) Method and composition
GB9012083D0 (en) Method and composition
GB9008585D0 (en) Composition and method
GB8923822D0 (en) Novel immunosuppressant compound and immunosuppressant composition
IE890980L (en) Bariumtitanate powder and compositions thereof